Eyetamins is a healthcare technology and life sciences company focused on therapeutics and consumer innovations in the $200B eye health and wellness space. They launched the company with natural supplements for eye health, which is a $37B industry. They have a patent-pending formula for dry eye, which is an $8B untapped market.
Yuri is a forward-thinking entrepreneur and thought leader who has a true passion for community and global impact projects. He has served in a...
Andrew Malloy spent a career on Wall Street and also happens to be part of a 3rd generation family office created because of his...
TMI is developing the POINT-GUARD, the first and only cerebral embolic protection device with dynamic Double-Edge Sealing. The seal adapts and conforms to complex...